In addition, overexpression of 14-3-3 zeta is an independent prognostic indicator for reduced DFS, and knockdown of 14-3-3 zeta expression by siRNA in BrCa cells effectively reduces tumor growth in vitro and in vivo [27]. Here, YWHAQ is linked to invasive breast carcinoma.